A new MRI test could spot a hidden Heart-Lung danger in babies

NCT ID NCT06440408

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This pilot study tests whether a special MRI technique can measure wall shear stress—the force of blood against vein walls—in the pulmonary veins of infants. These veins carry blood from the lungs to the heart, and narrowing them (pulmonary vein stenosis) is a life-threatening condition. The study includes infants with normal hearts and those with pulmonary vein stenosis, using ferumoxytol as a contrast agent to enhance the images. If successful, this approach could lead to better screening and treatment guidance for at-risk infants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ferumoxytol (contrast agent for cardiac MRI)
What this could lead to
If successful, this imaging technique could help identify infants at risk for pulmonary vein stenosis earlier and guide treatment decisions.
What could go wrong
This is a small pilot study with only 20 participants, so results may not apply broadly. The technique is experimental and may not reliably measure wall shear stress in all infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.